Dignitana (DIGN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net sales increased 4% year-over-year to 21.8 MSEK in Q2 2024, driven by strong device sales in Europe, while U.S. revenue remained flat compared to Q2 2023.
Operating result declined to -11.0 MSEK from -4.7 MSEK, impacted by severance costs and bad debt write-offs.
EBITDA was negative at -7.0 MSEK, down from -0.9 MSEK in Q2 2023.
Cash balance improved to 7.0 MSEK, supported by a fully subscribed rights issue raising 19.1 MSEK before costs.
CEO transition occurred in May 2024, with Fredrik Jonsson appointed as CEO.
Financial highlights
Net sales: 21.8 MSEK (up 4% year-over-year); total revenues: 22.0 MSEK.
Operating result: -11.0 MSEK (Q2 2023: -4.7 MSEK); net result after financial items: -11.5 MSEK (Q2 2023: -4.7 MSEK).
EBITDA: -7.0 MSEK (Q2 2023: -0.9 MSEK); EPS: -0.14 SEK (Q2 2023: -0.07 SEK).
Gross margin increased to 68% from 66% despite a 600 TSEK inventory write-down.
Cash flow from operating activities: -3.5 MSEK; total cash flow for the period: 4.1 MSEK.
Outlook and guidance
Management expects acceleration in U.S. sales entering Q3, with continued focus on optimizing device utilization and expanding business models.
Board and management believe current business plans and available credit facilities are sufficient to cover working capital needs for the next 12 months.
Latest events from Dignitana
- Sales growth, reimbursement wins, and cost control drive improved results amid funding needs.DIGN
Q3 202413 Jun 2025 - Sales growth and positive EBITDA mark progress as Paxman AB takeover advances.DIGN
Q1 20256 Jun 2025 - Record Q4 sales and new U.S. reimbursement rules position Dignitana for future growth.DIGN
Q4 20245 Jun 2025